{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:44:31Z","timestamp":1789497871122,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.atherosclerosis.2024.119094","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T03:41:33Z","timestamp":1734234093000},"page":"119094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction"],"prefix":"10.1016","volume":"401","author":[{"given":"L\u00e6rke Kristine","family":"Kyhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Davey","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-9560","authenticated-orcid":false,"given":"Sune Fallgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119094_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib2","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"Bmj"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119094_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119094_bib4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119094_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors","volume":"79","author":"Muzurovi\u0107","year":"2022","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.119094_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119094_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.119094_bib8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119094_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"issue":"9943","key":"10.1016\/j.atherosclerosis.2024.119094_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119094_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.119094_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119094_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/clinchem\/hvaa290","article-title":"Very low-density lipoprotein cholesterol may mediate a substantial component of the effect of obesity on myocardial infarction risk: the Copenhagen general population study","volume":"67","author":"Johansen","year":"2021","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119094_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119094_bib15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance Metabolomics in large-scale epidemiology: a primer on -omic technologies","volume":"186","author":"W\u00fcrtz","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119094_bib16","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/s41467-019-11311-9","article-title":"A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals","volume":"10","author":"Deelen","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119094_bib17","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","article-title":"Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen general population study","volume":"41","author":"Johansen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119094_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance Metabolomics in large-scale epidemiology: a primer on -omic technologies","volume":"186","author":"W\u00fcrtz","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119094_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib20","volume":"SI","year":"2019"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119094_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0000000000000429","article-title":"Remnant lipoproteins","volume":"28","author":"Varbo","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib22","series-title":"Regression Modeling Strategies","first-page":"582","author":"Harrell","year":"2015"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2024.119094_bib23","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib24","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","author":"Das Pradhan","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib25","unstructured":"Hartley AA-O, Santos Ferreira DA-O, et al. Metabolic Profiling of Adolescent Non-alcoholic Fatty Liver Disease. (2398-502X (Print))."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib26","series-title":"NAFLD Risk Alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 Show Divergent Metabolic Effects","first-page":"1460","author":"Sliz","year":"2018"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119094_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","article-title":"Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease","volume":"48","author":"Helgadottir","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119094_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1475-6773.2012.01440.x","article-title":"Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates","volume":"48","author":"Metcalfe","year":"2013","journal-title":"Health Serv. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119094_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.atherosclerosis.2024.119094_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2023.05.015","article-title":"High fat in blood and body and increased risk of clinically diagnosed non-alcoholic fatty liver disease in 105,981 individuals","volume":"376","author":"Kyhl","year":"2023","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119094_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000572","article-title":"Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM","volume":"8","author":"Hayward","year":"2021","journal-title":"BMJ Open Gastroenterology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119094_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:41Z","timestamp":1741844981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024015259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"alternative-id":["S0021915024015259"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119094","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119094"}}